J Neurol Surg B Skull Base
DOI: 10.1055/a-2297-9474
Review Article

Current Evidence in the Management of Central Skull Base Osteomyelitis: A Systematic Review

1   Department of Ear, Nose, and Throat (ENT), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
,
2   Department of Ear, Nose, and Throat (ENT), All India Institute of Medical Sciences (AIIMS), Rajkot, Rajkot, Gujarat, India
,
1   Department of Ear, Nose, and Throat (ENT), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
,
Sivaraman Ganesan
1   Department of Ear, Nose, and Throat (ENT), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
,
1   Department of Ear, Nose, and Throat (ENT), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
,
3   Department of Ear, Nose, and Throat (ENT), Christian Medical College Hospital, Vellore, Tamil Nadu, India
› Author Affiliations

Abstract

Objectives Based on current evidence, this systematic review focuses on various gray areas related to these patients' diagnosis, management, and follow-up in central skull base osteomyelitis (CSBO).

Study Design A systematic review of all case reports and observational studies.

Methods We systematically searched PubMed, Scopus database, Cochrane database, U.K. clinicaltrails.gov registry, and World Health Organization International Clinical Trials Registry Platform and included all reports as per our inclusion criteria. Data was analyzed systematically, and we made essential observations.

Results Out of 179 articles, 25 were selected according to inclusion criteria and quality assessment. Among the 44 patients, refractory headache (95%) was the most common presentation, followed by cranial nerve paralysis (82%) and Pseudomonas (32%) as the most common bacteria. Contrary to the available literature the disease cure was worse in those who underwent targeted biopsy (64% vs. 36%, p = 0.023) and surgical debridement (61% vs. 39%, p = 0.013) in the late stages of the disease.

Conclusion Otogenic osteomyelitis can spread to central skull bones in the absence of obvious ear symptoms. Early diagnosis and intervention of CSBO before progression to late stages can help decrease significant morbidity and mortality.

Authors' Contributions

L.K.P.: Data extraction, quality analysis, data interpretation, and manuscript writing.


G.U.: Data extraction, quality analysis, and manuscript writing.


S.P.: Data extraction, quality check, and data interpretation.


S.G.: Manuscript correction and statistical analysis.


A.A.: Manuscript correction, statistical analysis, and peer review.


R.T.: Manuscript correction, statistical analysis, and peer review.


Supplementary Material



Publication History

Received: 16 January 2024

Accepted: 31 March 2024

Accepted Manuscript online:
02 April 2024

Article published online:
30 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Johnson AK, Batra PS. Central skull base osteomyelitis: an emerging clinical entity. Laryngoscope 2014; 124 (05) 1083-1087
  • 2 Seki M, Yamaoka M, Honda T, Tokoro H, Matsushima S, Akiyama M. A pediatric case of central skull base osteomyelitis caused by Streptococcus milleri group infection and mimicking malignancy. Childs Nerv Syst 2020; 36 (07) 1569-1571
  • 3 Wagenaar AE, Mirsky DM, Stence NV, Wine TM, Chan KH. Infection of the spheno-occipital synchondrosis: a morbid complication following adenoidectomy. Int J Pediatr Otorhinolaryngol 2018; 111: 59-62
  • 4 Visosky AMB, Isaacson B, Oghalai JS. Circumferential petrosectomy for petrous apicitis and cranial base osteomyelitis. Otol Neurotol 2006; 27 (07) 1003-1013
  • 5 Jung DJ, Hong J, Cho HJ, Yoo MH, Lee KY. Clinical outcomes of otogenic skull base osteomyelitis. Eur Arch Otorhinolaryngol. 2021; 278 (08) 2817-2822
  • 6 Khan MA, Quadri SAQ, Kazmi AS. et al. A comprehensive review of skull base osteomyelitis: diagnostic and therapeutic challenges among various presentations. Asian J Neurosurg 2018; 13 (04) 959-970
  • 7 Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26 (3-4): 259-265
  • 8 Naghibi M, Smith RP, Baltch AL. et al. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res Clin Pract 1987; 4 (01) 27-35
  • 9 Chawdhary G, Hussain S, Corbridge R. Delayed diagnosis of central skull-base osteomyelitis with abscess: case report and learning points. Ann R Coll Surg Engl 2017; 99 (01) e24-e27
  • 10 Jacobo-Pinelli R, Guerrero-Paz JA, Lugo-Machado JA, Arvizu-Flores JA, Guerrero-Paz KP. Otogenic central skull base osteomyelitis with retropharyngeal extension: a case report. Cureus 2022; 14 (03) e22991
  • 11 See A, Tan TY, Gan EC. Atypical culture-negative skull base osteomyelitis masquerading as advanced nasopharyngeal carcinoma. Am J Otolaryngol 2016; 37 (03) 236-239
  • 12 Goh JPN, Karandikar A, Loke SC, Tan TY. Skull base osteomyelitis secondary to malignant otitis externa mimicking advanced nasopharyngeal cancer: MR imaging features at initial presentation. Am J Otolaryngol 2017; 38 (04) 466-471
  • 13 Chang PC, Fischbein NJ, Holliday RA. Central skull base osteomyelitis in patients without otitis externa: imaging findings. AJNR Am J Neuroradiol 2003; 24 (07) 1310-1316
  • 14 Moss WJ, Finegersh A, Narayanan A, Chan JYK. Meta-analysis does not support routine traditional nuclear medicine studies for malignant otitis. Laryngoscope 2020; 130 (07) 1812-1816
  • 15 Thomas R. Targeted skull base biopsies in the management of central skull base osteomyelitis. Clin Otolaryngol 2021; 46 (01) 72-74
  • 16 Cavel O, Fliss DM, Segev Y, Zik D, Khafif A, Landsberg R. The role of the otorhinolaryngologist in the management of central skull base osteomyelitis. Am J Rhinol 2007; 21 (03) 281-285
  • 17 Suresh K, Chari DA, Bartholomew RA. et al. A rare complication of chronic otitis media: central skull base osteomyelitis managed with combined endoscopic transmastoid and transsphenoidal debridement. Otol Neurotol 2022; 43 (03) e344-e347
  • 18 Ducic Y. Management of osteomyelitis of the anterior skull base and craniovertebral junction. Otolaryngol Head Neck Surg 2003; 128 (01) 39-42
  • 19 Lee S, Hooper R, Fuller A, Turlakow A, Cousins V, Nouraei R. Otogenic cranial base osteomyelitis: a proposed prognosis-based system for disease classification. Otol Neurotol 2008; 29 (05) 666-672
  • 20 Patil NR, Tripathi M, Charaya K, Angrup A, Ahuja C, Mohindra S. Skull base osteomyelitis by Pandoraea apista: an unusual pathogen at unusual location - a case report. Surg Neurol Int 2021; 12: 447
  • 21 Abou-Al-Shaar H, Mulvaney GG, Alzhrani G, Gozal YM, Oakley GM, Couldwell WT. Nocardial clival osteomyelitis secondary to sphenoid sinusitis: an atypical skull base infection. Acta Neurochir (Wien) 2019; 161 (03) 529-534
  • 22 Bruschini L, Berrettini S, Christina C. et al. Extensive skull base osteomyelitis secondary to malignant otitis externa. J Int Adv Otol 2019; 15 (03) 463-465
  • 23 Weitzman RE, Parikh AS, Gadkaree SK, Corrales CE. Skull base osteomyelitis complicated by petrous internal carotid artery blowout. Ear Nose Throat J 2021; 100 (5_suppl, suppl): 790S-794S
  • 24 Kumpitsch C, Koskinen K, Schöpf V, Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol 2019; 17 (01) 87
  • 25 Dimitri-Pinheiro S, Soares R, Barata P. The microbiome of the nose-friend or foe?. Allergy Rhinol (Providence) 2020; 11: 2152656720911605
  • 26 Byun YJ, Patel J, Nguyen SA, Lambert PR. Hyperbaric oxygen therapy in malignant otitis externa: a systematic review of the literature. World J Otorhinolaryngol Head Neck Surg 2020; 7 (04) 296-302